GGrantIndex
← Leaderboards

Mayo Clinic Rochester

Rochester, MN

Compare ↔
$4,255,949,788
Total funding
2,618
Grants

Funding over time

peak $342.2M · FY2005–25
$500M$375M$250M$125M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,324,665,080 · 2569
AHRQ$13,401,199 · 17
CDC$10,469,991 · 6
NSF$7,956,407 · 21
FDA$7,255,104 · 6
HHS (Other)$3,148,217 · 2

By mechanism

R01$2,095,036,231 · 985
U01$370,940,434 · 77
U24$227,170,227 · 15
P50$173,736,267 · 200
P30$166,496,274 · 200
U10$161,167,359 · 22

Investigators at Mayo Clinic Rochester

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Saad J. Kenderian$4,264,7862 gr2Juan P Brito Campana$3,769,6613 gr3Jessica Danielle Austin$2,392,1111 gr4Joshua R. Smith$2,279,5072 gr5Haitao Wang$2,061,1421 gr6Malay Choudhury$1,908,5932 gr7Tyler S Oesterle$1,875,0001 gr8Brent A Bauer$1,772,4512 gr

Emerging Leaders

6–10 yrs in

1Hilal Maradit Kremers$9,283,5013 gr2Alexander Egbe$7,415,2973 gr3Sunghwan Sohn$6,722,6093 gr4Ian R Lanza$6,681,2753 gr5Darren Baker$6,151,7164 gr6Kip A Ludwig$5,064,0034 gr7Joan M. Griffin$4,985,9495 gr8Ukpong Bassey Eyo$4,876,6773 gr

All-Time

Most funded here, all years

1Adam L Boxer$60,072,5706 gr2Stephen B Kritchevsky$26,261,35012 gr3Peter C. Harris$25,244,93110 gr4Cornelia M Weyand$24,510,6058 gr5Fergus Joseph Couch$22,197,2319 gr6Louis James Maher$21,515,13610 gr7Lilach O Lerman$20,609,19913 gr8Y. S. Prakash$20,260,3788 gr

Largest grants

Precision Medicine Initiative Cohort Program Biobank$54,240,312
U24 · FY2020 · OD
Precision Medicine Initiative Cohort Program Biobank$28,241,165
U24 · FY2016 · OD
Precision Medicine Initiative Cohort Program Biobank$27,340,600
U24 · FY2023 · OD
Precision Medicine Initiative Cohort Program Biobank$26,218,000
U24 · FY2017 · OD
Precision Medicine Initiative Cohort Program Biobank$26,197,843
U24 · FY2024 · OD
All of Us Biobank$19,232,744
OT2 · FY2025 · OD
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2)$16,947,844
U19 · FY2025 · AG
Precision Medicine Initiative Cohort Program Biobank$15,329,300
U24 · FY2022 · OD
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)$13,195,325
U19 · FY2024 · AG
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)$13,002,977
U19 · FY2021 · AG
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)$12,764,241
U19 · FY2019 · AG
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)$12,618,678
U19 · FY2023 · AG
Mayo Clinic Center for clinical and Translational Science (CCaTS)$12,490,175
UL1 · FY2017 · TR
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)$12,228,673
U19 · FY2020 · AG
Mayo Clinic Center for Clinical and Translational Research$11,624,779
UL1 · FY2007 · RR
Alliance NCORP Research Base$11,328,914
UG1 · FY2017 · CA
Mayo Clinic Center for Clinical and Translational Research$10,989,928
UL1 · FY2008 · RR
Alliance NCORP Research Base$10,950,397
UG1 · FY2015 · CA
Mayo Clinic Center for Clinical and Translational Research$10,941,178
UL1 · FY2009 · RR
Mayo Clinic Center for Clinical and Translational Research$10,919,773
UL1 · FY2010 · RR